Gabriela Brzuska - Search Results

Year	Number of Results
2018	1
2019	2
2020	1
2022	4
2023	3
2024	0

1

Production and Biomedical Application of Flavivirus-like Particles.

Krol E, Brzuska G, Szewczyk B. Krol E, et al. Among authors: brzuska g. Trends Biotechnol. 2019 Nov;37(11):1202-1216. doi: 10.1016/j.tibtech.2019.03.013. Epub 2019 Apr 16. Trends Biotechnol. 2019. PMID: 31003718 Free article. Review.

2

Anti-HCV and Zika activities of ribavirin C-nucleosides analogues.

Gonzalez S, Brzuska G, Ouarti A, Gallier F, Solarte C, Ferry A, Uziel J, Krol E, Lubin-Germain N. Gonzalez S, et al. Among authors: brzuska g. Bioorg Med Chem. 2022 Aug 15;68:116858. doi: 10.1016/j.bmc.2022.116858. Epub 2022 May 29. Bioorg Med Chem. 2022. PMID: 35661850

3

In vitro reconstitution reveals a key role of human mitochondrial EXOG in RNA primer processing.

Karlowicz A, Dubiel AB, Czerwinska J, Bledea A, Purzycki P, Grzelewska M, McAuley RJ, Szczesny RJ, Brzuska G, Krol E, Szczesny B, Szymanski MR. Karlowicz A, et al. Among authors: brzuska g. Nucleic Acids Res. 2022 Aug 12;50(14):7991-8007. doi: 10.1093/nar/gkac581. Nucleic Acids Res. 2022. PMID: 35819194 Free PMC article.

4

Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles.

Brzuska G, Szewczyk B, Krol E. Brzuska G, et al. Microbiol Spectr. 2023 Feb 14;11(1):e0288522. doi: 10.1128/spectrum.02885-22. Epub 2022 Dec 21. Microbiol Spectr. 2023. PMID: 36541807 Free PMC article.

5

The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus.

Brzuska G, Zimna M, Baranska K, Szewczyk B, Strakova P, Ruzek D, Krol E. Brzuska G, et al. Microbiol Spectr. 2023 Jun 15;11(3):e0256422. doi: 10.1128/spectrum.02564-22. Epub 2023 May 18. Microbiol Spectr. 2023. PMID: 37199661 Free PMC article.

6

Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles.

Zimna M, Brzuska G, Salát J, Svoboda P, Baranska K, Szewczyk B, Růžek D, Krol E. Zimna M, et al. Among authors: brzuska g. Antiviral Res. 2023 Jan;209:105511. doi: 10.1016/j.antiviral.2022.105511. Epub 2022 Dec 27. Antiviral Res. 2023. PMID: 36581050 Free article.

7

Antiviral Activity of Uridine Derivatives of 2-Deoxy Sugars against Tick-Borne Encephalitis Virus.

Krol E, Wandzik I, Brzuska G, Eyer L, Růžek D, Szewczyk B. Krol E, et al. Among authors: brzuska g. Molecules. 2019 Mar 21;24(6):1129. doi: 10.3390/molecules24061129. Molecules. 2019. PMID: 30901934 Free PMC article.

8

Anti-Tick-Borne Encephalitis Virus Activity of Novel Uridine Glycoconjugates Containing Amide or/and 1,2,3-Triazole Moiety in the Linker Structure.

Brzuska G, Pastuch-Gawolek G, Krawczyk M, Szewczyk B, Krol E. Brzuska G, et al. Pharmaceuticals (Basel). 2020 Dec 13;13(12):460. doi: 10.3390/ph13120460. Pharmaceuticals (Basel). 2020. PMID: 33322151 Free PMC article.

9

Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral Compounds.

Krol E, Pastuch-Gawolek G, Chaubey B, Brzuska G, Erfurt K, Szewczyk B. Krol E, et al. Among authors: brzuska g. Molecules. 2018 Jun 13;23(6):1435. doi: 10.3390/molecules23061435. Molecules. 2018. PMID: 29899276 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year